Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publication Artículo científico (JournalArticle)

Actionable Variants of Unknown Significance in Inherited Arrhythmogenic Syndromes: A Further Step Forward in Genetic Diagnosis

  • Martínez Barrios, Estefanía
  • Greco, Andrea
  • Cruzalegui, José
  • Cesar, Sergi
  • Díez Escuté, Nuria
  • Cerralbo, Patricia
  • Chipa, Fredy
  • Zschaeck, Irene
  • Fogaça-da-Mata, Miguel
  • Diez López, Carles
  • Arbelo, Elena
  • Grassi, Simone
  • Oliva, Antonio
  • Toro Cebada, Rocío
  • Sarquella Brugada, Georgia
  • Campuzano, Oscar
Background/Objectives: Inherited arrhythmogenic syndromes comprise a heterogenic group of genetic entities that lead to malignant arrhythmias and sudden cardiac death. Genetic testing has become crucial to understand the disease etiology and allow for the early identification of relatives at risk; however, it requires an accurate interpretation of the data to achieve a clinically actionable outcome. This is particularly challenging for the large number of rare variants obtained by current high-throughput techniques, which are mostly classified as of unknown significance. Methods: In this work, we present a new algorithm for the genetic interpretation of the remaining rare variants in order to shed light on their potential clinical implications and reduce the burden of unknown significance. Results: Our study illustrates the potential utility of our individualized comprehensive stepwise analyses focused on the rare variants associated with IAS, which are currently classified as ambiguous, to further determine their trends towards pathogenicity or benign traits. Conclusions: We advocate for personalized disease-focused population frequency data and family segregation analyses for all rare variants that remain ambiguous to further clarify their role. The current ambiguity should not influence medical decisions, but a potential deleterious role would suggest a closer clinical follow-up and frequent genetic data review for a more personalized clinical approach.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publication Artículo científico (JournalArticle)

Interpreting the actionable clinical role of rare variants associated with short QT syndrome

  • Martínez Barrios, Estefanía
  • Greco, Andrea
  • Cruzalegui, José
  • Cesar, Sergi
  • Díez Escuté, Nuria
  • Cerralbo, Patricia
  • Chipa, Fredy
  • Zschaeck, Irene
  • Slanovic, Leonel
  • Mangas Rojas, Alipio
  • Toro Cebada, Rocío
  • Campuzano, Oscar
  • Sarquella-Brugada, Georgia
Genetic testing is recommended in the diagnosis of short QT syndrome. This rare inherited lethal entity is characterized by structural normal hearts with short QT intervals in the electrocardiogram. Few families diagnosed with this arrhythmogenic disease have been reported worldwide so far, impeding a comprehensive understanding of this syndrome. Unraveling the origin of the disease helps to the early identification of genetic carriers at risk. However, only rare variants with a definite deleterious role should be actionable in clinical practice. Our aim was to perform a comprehensive update and reinterpretation, according to the American College of Medical Genetics and Genomics recommendations of all rare variants currently associated with short QT syndrome. We identified 34 rare variants. Reanalysis showed that only nine variants played a deleterious role associated with a definite short QT syndrome phenotype. These variants were located in the four main genes: KCNQ1, KCNH2, KCNJ2 or SLC4A3. Additional rare variants located in other genes were associated with other conditions with phenotypic shortened QT intervals, but not definite diagnosis of short QT syndrome. Periodically updating of rare variants, especially those previously classified as unknown, helps to clarify the role of rare variants and translate genetic data into clinical practice.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Molecular autopsy, Twenty years of post-mortem diagnosis in sudden cardiac death

  • Martínez-Barrios, Estefanía|||0000-0002-5856-1906
  • Grassi, Simone
  • Brión, María
  • Toro, Rocío
  • Cesar, Sergi|||0000-0002-2798-1756
  • Cruzalegui, José|||0000-0003-2382-0979
  • Coll, Mònica|||0000-0003-1214-803X
  • Alcalde, Mireia|||0000-0002-7222-0913
  • Brugada, Ramon|||0000-0001-6607-3032
  • Greco, Andrea
  • Ortega-Sánchez, Marisa|||0000-0003-0764-1452
  • Barberia, Eneko|||0000-0001-5804-3597
  • Oliva, Antonio
  • Sarquella-Brugada, Georgia|||0000-0002-6857-8904
  • Campuzano, Óscar|||0000-0001-5298-5276
In the forensic medicine field, molecular autopsy is the post-mortem genetic analysis performed to attempt to unravel the cause of decease in cases remaining unexplained after a comprehensive forensic autopsy. This negative autopsy, classified as negative or non-conclusive, usually occurs in young population. In these cases, in which the cause of death is unascertained after a thorough autopsy, an underlying inherited arrhythmogenic syndrome is the main suspected cause of death. Next-generation sequencing allows a rapid and cost-effectives genetic analysis, identifying a rare variant classified as potentially pathogenic in up to 25% of sudden death cases in young population. The first symptom of an inherited arrhythmogenic disease may be a malignant arrhythmia, and even sudden death. Early identification of a pathogenic genetic alteration associated with an inherited arrhythmogenic syndrome may help to adopt preventive personalized measures to reduce risk of malignant arrhythmias and sudden death in the victim's relatives, at risk despite being asymptomatic. The current main challenge is a proper genetic interpretation of variants identified and useful clinical translation. The implications of this personalized translational medicine are multifaceted, requiring the dedication of a specialized team, including forensic scientists, pathologists, cardiologists, pediatric cardiologists, and geneticists.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Congenital LMNA-related muscular dystrophy in paediatrics: cardiac management in monozygotic twins

  • Martínez Olorón, Patricia
  • Alegría, Iosune
  • Cesar, Sergi
  • Olmo, Bernat del
  • Martínez-Barrios, Estefanía
  • Carrera-García, Laura
  • Natera-de Benito, Daniel
  • Nascimento, Andrés
  • Campuzano, Oscar
  • Sarquella-Brugada, Georgia
Pathogenic variants in LMNA have been associated with a wide spectrum of muscular conditions: the laminopathies. LMNA-related congenital muscular dystrophy is a laminopathy characterised by the early onset of symptoms and often leads to a fatal outcome at young ages. Children face a heightened risk of malignant arrhythmias. No established paediatric protocols for managing this condition are available. We review published cases and provide insights into disease progression in two twin sisters with LMNA-related muscular dystrophy. Our objective is to propose a cardiac surveillance and management plan tailored specifically for paediatric patients. We present a family of five members, including two twin sisters with LMNA-related muscular dystrophy. A comprehensive neuromuscular and cardiac work-up was performed in all family members. Genetic analysis using massive sequencing technology was performed in both twins. Clinical assessment showed that only the twins showed diagnoses of LMNA-related muscular dystrophy. Follow-up showed an early onset of symptoms and life-threatening arrhythmias, with differing disease progressions despite both twins passing away. Genetic analysis identified a de novo rare missense deleterious variant in the LMNA gene. Other additional rare variants were identified in genes associated with myasthenic syndrome. Early-onset neuromuscular symptoms could be related to a prognosis of worse life-threatening arrhythmias in LMNA related muscular dystrophy. Being a carrier of other rare variants may be a modifying factor in the progression of the phenotype, although further studies are needed. There is a pressing need for specific cardiac recommendations tailored to the paediatric population to mitigate the risk of malignant arrhythmias., This study would not have been possible without the support of grants for research projects of Instituto de Salud Carlos III, Fondo Investigación Sanitaria-FIS-(PI21/00094) and 'Fundación Andrés Marcio-Niños contra la Laminopatía'. CIBERCV and CIBERER are initiatives of the ISCIII (Carlos III Health Institute), Ministry of Economy and Competitiveness of Spain. IDIBGI and Fundació Sant Joan de Dèu are 'CERCA Programme/Generalitat de Catalunya'.